PyroGenesis Canada Inc.
PYRGF- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001743344
No open-market purchases or sales by PyroGenesis Canada Inc. insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $14.5K in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding PyroGenesis Canada Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 21 | 20 | −1 |
| Shares | 766.5K | 488.6K | −277.9K (−36.2%) |
| Value | $533.2K | $210.7K | −$322.5K (−60.5%) |
New holders (3)
Institutions that held PyroGenesis Canada Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 24,257 | $10.5K | 0.00% |
| Hibernia Wealth Partners, LLC | 3,100 | $1.30K | 0.00% |
| UBS Group AG | 1,494 | $627 | 0.00% |
Sold out (4)
Institutions that held PyroGenesis Canada Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Toronto Dominion Bank | 65,400 | $45.0K |
| Goldman Sachs Group Inc | 38,467 | $27.1K |
| Susquehanna International Group, LLP | 11,624 | $8.18K |
| Tower Research Capital LLC (TRC) | 162 | $112 |